We discovered that the knockdown of FOXC1 significantly reduced the expression of CD44, and CD133 at the protein and mRNA levels, subsequently curtailing the proportion of CD44+ cells within esophageal cancer cell lines ECA-109 and KYSE-150. The gene discussed is PROM1; the disease is esophageal cancer.